Abliva develops medicines for the treatment of primary mitochondrial diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: Scheeletorget 1
City: Lund
State: skåne län
Zip: 223 81
Country: SE
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell&s;s energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2016 | Isomerase Therapeutics | Funding Round | - |
8/2016 | Isomerase Therapeutics | Funding Round | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2015 | Post-IPO Equity | $7.5M | 2/2015 | Post-IPO Equity | $3.3M | 3/2019 | Post-IPO Equity | 1 | $3M |
Nyenburgh Investment Partners Nyenburgh Investment Partners Nyenburgh Investment Partners Nyenburgh Investment Partners |
8/2018 | Grant | 2 | $4.1M |
U.S. Department of Defense Congressionally Directed Medical Research Programs Congressionally Directed Medical Research Programs U.S. Department of Defense U.S. Department of Defense Congressionally Directed Medical Research Programs Congressionally Directed Medical Research Programs U.S. Department of Defense |
6/2017 | Grant | 1 | $115.1k |
Vinnova Vinnova Vinnova Vinnova |
5/2022 | Post-IPO Equity | $0 |
IP Group IP Group |
4/2020 | Post-IPO Equity | 1 | $2M |
Hadean Ventures Hadean Ventures |
5/2022 | Post-IPO Equity | 1 | $20.5M |
IP Group IP Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|